The results of the multifactorial Cox regression analysis indicated that c-Myc and IRF5 could be used as prognostic biomarkers for bladder cancer; however, we found no significant differences in IRF5 expression at different stages of bladder cancer. This evidence concerns the gene MYC and urinary bladder cancer.